-
The New England Journal of Medicine | RC48-C016 Study: A Major Breakthrough in China’s Urologic Oncology Field
The New England Journal of Medicine 2025-11-27View -
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Nature Medicine 2024-10-10View -
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia:First-in-Human,Phase I Trial
Journal of Clinical Oncology 2021-7-29View -
JCO Publication | Prof. Jin Li’s Team Reports Phase I Results of SHR-A1811 in HER2-Expressing GC/GEJ and CRC
Journal of Clinical Oncology 2026-3-24View
- 1
- 2
- 3
- 4
- 5
- 6
- 8







